FDA
.report
PMA
PMN
De Novo
MAUDE
GUDID
NDC
DailyMed
Drug Applications
NDC 51311-026
NDC 51311-026
NDC 51311-026 is a in the
category. It is labeled and distributed by .
Proprietary Name
NDC 51311-026
Marketing Category
/
Packaging
NDC SPL Data Element Entries
NDC 51311-026-10 [51311002610]
Rilexine TABLET, CHEWABLE
Marketing Category
NADA
Application Number
NADA141326
Product Type
PRESCRIPTION ANIMAL DRUG
Marketing Start Date
2012-09-01
Drug Details
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.